Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02768948

Recruitment Status : Unknown

Verified July 2018 by Centre Hospitalier Universitaire de Nice.
Recruitment status was: Recruiting

First Posted : May 11, 2016

Last Update Posted : November 21, 2018

Sponsor:

Information provided by (Responsible Party):

Centre Hospitalier Universitaire de Nice

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	July 2019
Estimated Study Completion Date :	July 2019

To Top